John Robt Srigley MD, FRCPC, FRCPath, FRCPA

Dr. Srigley is a graduate of the Faculty of Medicine, University of Toronto, who undertook postgraduate training in anatomic and oncologic pathology at the University of Toronto and MD Anderson Cancer Center in Houston, Texas. Dr. Srigley has practiced surgical and urologic pathology for over 30 years and is currently the Chief and Medical Director of the Program of Laboratory Medicine and Genetics at Trillium Health Partners, one of the largest community-academic hospitals in Canada.

He is also a Professor in the Department of Pathology and Molecular Medicine at McMaster University. Dr. Srigley is an international consultant and educator in surgical and urologic pathology and has contributed extensively to the literature. He is an editor/author of three textbooks on urological pathology including the series 3 AFIP Fascicle on Tumors of the Prostate Gland. Dr. Srigley has been an author and member of the international working groups for the 2004 and 2016 WHO Bluebooks on Tumors of the Urinary System and Male Genital Organs.

He is the Canadian representative on the American Joint Committee on Cancer and a member of the AJCC male genital system expert panel. He is a Past President of the International Society of Urological Pathologists (ISUP) and the Ontario Association of Pathologists. His research interests include clinical-pathological and translational studies of urological cancer, population-level quality initiatives in cancer pathology and the role of the pathologist in cancer control. Dr. Srigley is also a founding board member of the International Collaboration on Cancer Reporting (ICCR) and has provided advice on population-level standardized cancer pathology reporting to the College of American Pathologists as well as groups in Australasia, Poland, Norway and Brazil.